We just received data on a new analyst forecast for $IONS. Mitchell S. Kapoor from HC Wainwright & Co. set a price target of 70.0 for IONS.
To track analyst ratings and price targets for $IONS, check out Quiver Quantitative's $IONS forecast page.
$IONS Price Targets
Multiple analysts have issued price targets for $IONS recently. We have seen 10 analysts offer price targets for $IONS in the last 6 months, with a median target of $59.5.
Here are some recent targets:
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $70.0 on 08/22/2025
- Esther Rajavelu from UBS set a target price of $46.0 on 08/12/2025
- Michael Ulz from Morgan Stanley set a target price of $62.0 on 07/31/2025
- Gary Nachman from Raymond James set a target price of $64.0 on 07/31/2025
- Gena Wang from Barclays set a target price of $57.0 on 07/01/2025
- Jessica Fye from JP Morgan set a target price of $48.0 on 06/12/2025
- Debjit Chattopadhyay from Guggenheim set a target price of $64.0 on 05/01/2025
$IONS Insider Trading Activity
$IONS insiders have traded $IONS stock on the open market 12 times in the past 6 months. Of those trades, 1 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $IONS stock by insiders over the last 6 months:
- MICHAEL R HAYDEN purchased 15,000 shares for an estimated $477,900
- C FRANK BENNETT (EVP, Chief Scientific Officer) sold 10,000 shares for an estimated $439,776
- RICHARD S GEARY (EVP, Chief Development Officer) sold 10,000 shares for an estimated $428,593
- EUGENE SCHNEIDER (EVP, Chf Clinical Develop Ofcr) sold 9,549 shares for an estimated $408,701
- B LYNNE PARSHALL has made 0 purchases and 2 sales selling 5,000 shares for an estimated $209,646.
- BRETT P MONIA (Chief Executive Officer) has made 0 purchases and 3 sales selling 3,732 shares for an estimated $162,380.
- JOSEPH BAROLDI (EVP, Chief Business Officer) sold 3,928 shares for an estimated $111,555
- KYLE JENNE (EVP, Chf GL Pdt Str Ofcr) sold 3,016 shares for an estimated $85,533
- BRIAN BIRCHLER (EVP, Corp and Development Ops) sold 680 shares for an estimated $19,291
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IONS Hedge Fund Activity
We have seen 199 institutional investors add shares of $IONS stock to their portfolio, and 209 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 2,724,400 shares (+253.3%) to their portfolio in Q2 2025, for an estimated $107,641,044
- ORBIMED ADVISORS LLC removed 2,540,136 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $100,360,773
- WELLINGTON MANAGEMENT GROUP LLP removed 2,070,645 shares (-24.6%) from their portfolio in Q2 2025, for an estimated $81,811,183
- MILLENNIUM MANAGEMENT LLC added 2,014,157 shares (+317.0%) to their portfolio in Q2 2025, for an estimated $79,579,343
- CITADEL ADVISORS LLC removed 1,985,081 shares (-57.0%) from their portfolio in Q2 2025, for an estimated $78,430,550
- CLEARBRIDGE INVESTMENTS, LLC removed 1,618,220 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $48,821,697
- NORGES BANK removed 1,264,508 shares (-73.7%) from their portfolio in Q2 2025, for an estimated $49,960,711
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
